Boston Partners’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-198,827
| Closed | -$18.3M | – | 707 |
|
2024
Q1 | $18.3M | Sell |
198,827
-4,870
| -2% | -$449K | 0.02% | 339 |
|
2023
Q4 | $19.4M | Sell |
203,697
-8,004
| -4% | -$761K | 0.03% | 333 |
|
2023
Q3 | $19.7M | Sell |
211,701
-12,534
| -6% | -$1.17M | 0.03% | 310 |
|
2023
Q2 | $20.5M | Sell |
224,235
-205,004
| -48% | -$18.8M | 0.03% | 308 |
|
2023
Q1 | $32M | Buy |
429,239
+104,737
| +32% | +$7.81M | 0.04% | 261 |
|
2022
Q4 | $27.7M | Buy |
324,502
+74,553
| +30% | +$6.36M | 0.04% | 266 |
|
2022
Q3 | $24M | Buy |
249,949
+47,416
| +23% | +$4.55M | 0.04% | 275 |
|
2022
Q2 | $21.7M | Buy |
202,533
+128,588
| +174% | +$13.8M | 0.03% | 303 |
|
2022
Q1 | $12.7M | Buy |
73,945
+67,194
| +995% | +$11.6M | 0.02% | 350 |
|
2021
Q4 | $1.09M | Sell |
6,751
-679
| -9% | -$110K | ﹤0.01% | 521 |
|
2021
Q3 | $1.11M | Buy |
+7,430
| New | +$1.11M | ﹤0.01% | 512 |
|